Vol. 39 Suppl. 1 2011
Clinical Evaluation of C.E.R.A.（Continuous Eythropoietin Receptor Activator）, a Novel Long-acting Erythropoiesis Stimulating Agent
【Hemodialysis】
A dose-finding study of C.E.R.A.（continuous erythropoietin receptor activator）in renal anemia patients on hemodialysis
―A randomized double-blind comparative study―
E. Kinugasa, et al.
Jpn Pharmacol Ther 2010 39(s1) s9-19
Clinical efficacies of C.E.R.A.（continuous erythropoietin receptor activator）administered intravenously to epoetin
（EPO）naïe renal anemia patients on hemodialysis
―Phase III study―
Y. Watanabe, et al.
Jpn Pharmacol Ther 2011 39(s1) s21-30
Switching and maintenance study of intravenous C.E.R.A.（continuous erythropoietin receptor activator）after switching from rHuEPO in hemodialysis patients
Y. Tsuruta, et al.
Jpn Pharmacol Ther 2010 39(s1) s31-42
【Chronic kidney disease not on dialysis】
Dose-finding and long-term studies with C.E.R.A.（continuous erythropoietin receptor activator）administered subcutaneously（SC）or intravenously（IV）in Japanese patients with chronic
kidney disease（CKD）not on dialysis
K. Hori, et al.
Jpn Pharmacol Ther 2010 39(s1) s43-54
Effect of hemoglobin（Hb）maintenance of subcutaneous（SC）or intravenous（IV）C.E.R.A.（continuous erythropoietin receptor activator）in chronic kidney disease（CKD）patients
not on dialysis
Y. Yuzawa, et al.
Jpn Pharmacol Ther 2011 39(s1) s55-68
【Peritoneal dialysis】
Effect of haemoglobin（Hb）maintenance of subcutaneous（SC）or intravenous（IV）C.E.R.A.（continuous erythropoietin receptor activator）in renal anemia patients on peritoneal dialysis
M. Hiramatsu, et al.
Jpn Pharmacol Ther 2011 39(s1) s69-78
【APPENDIX】
Pharmacokinetic and pharmacodynamic characteristics of C.E.R.A.,
a novel continuous erythropoietin receptor activator
─Results of pre-clinical studies─
M. Tamura, et al.
Jpn Pharmacol Ther 2011 39(s1) s249-58
A phase I clinical study of Ro50－3821
―A single subcutaneous dose study―
T. Tanaka, et al.
Jpn Pharmacol Ther 2011 39(s1) s1145-57
Pharmacokinetic properties of C.E.R.A.（continuous erythropoietin receptor activator）in Japanese chronic kidney disease patients not on dialysis
T. Naruse, et al.
Jpn Pharmacol Ther 2011 39(s1) s1159-74
Pharmacokinetics of C.E.R.A.（continuous erythropoietin receptor
activator）in Japanese chronic kidney disease patients on dialysis
T. Hayashi, et al.
Jpn Pharmacol Ther 2010 38(s1) s1175-90
